fluorouracil has been researched along with stearic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, X; Yu, BT; Zhang, ZR | 1 |
| Kumar, RV; Sinha, VR | 1 |
| Beijnen, JH; Huitema, AD; Keizer, RJ; Meulenaar, J; Nuijen, B; Schellens, JH | 1 |
| Bano, S; Deeba, F; Gopinath, P; Kulshreshtha, A; Kumar, B; Kumar, V; Negi, YS | 1 |
| Chang, CY; Pan, TM | 1 |
| Agrawal, G; Deeba, F; Gopinath, P; Kulshreshtha, A; Kumar, A; Kumar, B; Negi, YS; Priyadarshi, R | 1 |
6 other study(ies) available for fluorouracil and stearic acid
| Article | Year |
|---|---|
Enhanced liver targeting by synthesis of N1-stearyl-5-Fu and incorporation into solid lipid nanoparticles.
Topics: Animals; Drug Delivery Systems; Drug Stability; Female; Fluorouracil; Liposomes; Liver; Male; Mice; Microscopy, Electron; Nanotechnology; Particle Size; Rabbits; Stearic Acids | 2003 |
Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
Topics: Antimetabolites, Antineoplastic; Cellulose; Colon; Colorectal Neoplasms; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Excipients; Fluorouracil; Hardness; Humans; Hydrogen-Ion Concentration; Lactose; Pharmacokinetics; Polymethacrylic Acids; Polyvinyls; Pressure; Pyrrolidines; Solubility; Stearic Acids; Tablets; Tablets, Enteric-Coated; Talc | 2011 |
Development of an extended-release formulation of capecitabine making use of in vitro-in vivo correlation modelling.
Topics: Antimetabolites, Antineoplastic; Area Under Curve; Calorimetry, Differential Scanning; Capecitabine; Chemistry, Pharmaceutical; Delayed-Action Preparations; Deoxycytidine; Desiccation; Drug Compounding; Excipients; Fluorouracil; Models, Chemical; Povidone; Silicon Dioxide; Solubility; Stearic Acids; Tablets; X-Ray Diffraction | 2014 |
Lipophilic 5-fluorouracil prodrug encapsulated xylan-stearic acid conjugates nanoparticles for colon cancer therapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Colonic Neoplasms; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fluorouracil; Hemolysis; Humans; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Nanoparticles; Particle Size; Prodrugs; Spectroscopy, Fourier Transform Infrared; Stearic Acids; Xenograft Model Antitumor Assays; Xylans | 2019 |
Identification of bioactive compounds in Lactobacillus paracasei subsp. paracasei NTU 101-fermented reconstituted skimmed milk and their anti-cancer effect in combination with 5-fluorouracil on colorectal cancer cells.
Topics: Antineoplastic Agents; Autophagy-Related Protein 5; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cultured Milk Products; Fermentation; Fluorouracil; Humans; Lacticaseibacillus paracasei; NF-kappa B; Palmitic Acid; Stearic Acids | 2019 |
Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Curcumin; Disulfides; Drug Delivery Systems; Drug Liberation; Drug Stability; Fluorouracil; Hemolysis; HT29 Cells; Humans; Nanoparticles; Neoplasms; Oxidation-Reduction; Particle Size; Prodrugs; Spectroscopy, Fourier Transform Infrared; Stearic Acids; Xylans | 2020 |